Fractyl Health Announces the Initiation of a Global Registry Study of the Revita System™ in Patients With Inadequately Controlled Type 2 Diabetes (T2D)

By /

Fractyl Health today announces the initiation of its Revita® Global Registry Program in Germany.

Scroll to Top